Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other Accumulated Expenses (2016 - 2022)

Historic Other Accumulated Expenses for Alaunos Therapeutics (TCRT) over the last 9 years, with Q4 2022 value amounting to $169000.0.

  • Alaunos Therapeutics' Other Accumulated Expenses rose 119.76% to $169000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $169000.0, marking a year-over-year increase of 119.76%. This contributed to the annual value of $169000.0 for FY2022, which is 119.76% up from last year.
  • As of Q4 2022, Alaunos Therapeutics' Other Accumulated Expenses stood at $169000.0, which was up 119.76% from $167000.0 recorded in Q4 2021.
  • Alaunos Therapeutics' 5-year Other Accumulated Expenses high stood at $169000.0 for Q4 2022, and its period low was $167000.0 during Q4 2021.